What are Some of the Treatment Options for Breast Cancer?
MEDICAL ANIMATION TRANSCRIPT: Breast cancer is a disease where some of the cells in the breast begin to grow uncontrollably. Treatments for breast cancer can include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, and immunotherapy. There are several types of
From playlist Healthcare Patient Education Animations
Why Is Breast Cancer So Common?
Check us out on iTunes! http://dne.ws/1NixUds Please Subscribe! http://testu.be/1FjtHn5 Scientists know that women with a gene called BRCA1 have an increased risk for breast and ovarian cancer, but everyone could stand to be more aware of the dangers. + + + + + + + + Previous E
From playlist Breasts: What They Do, Why We Have Them, And How They Can Change Your Life
Will We Ever Cure Breast Cancer?
Breast cancer is the second most common cancer diagnosed in women in the United States, right behind skin cancer. But how far have we come in understanding this disease? » Subscribe to Seeker! http://bit.ly/subscribeseeker » Watch more SICK | http://bit.ly/SICKplaylist While breast cancer
From playlist SICK | Season 2 | Seeker
Nanoparticle Technology to Fight Ovarian Cancer
As part of Women's Health Research at Yale continuing video series, we want to share the work of our Pilot Project Program investigators - who are researching a variety of the most relevant women's health concerns. This first video, featuring a pilot study by Drs. Mark Saltzman and Alessa
From playlist Women's Health Research at Yale
Ruth Travis, University of Oxford - Stanford Big Data 2015
Bringing together thought leaders in large-scale data analysis and technology to transform the way we diagnose, treat and prevent disease. Visit our website at http://bigdata.stanford.edu/.
From playlist Big Data in Biomedicine Conference 2015
Laureate Eric Betzig ignored the traditional boundaries of academic disciplines. He attributes his success to a background in industry. Should young scientists look outside of the university system to progress their careers? A sponsor message from Mars, Incorporated – partner of the Linda
From playlist Lindau Meetings of Nobel Laureates
Vitamin D: It's Not Just For Bones Anymore
December 12, 2007 presentation by David Feldman for the Stanford School of Medicine Medcast lecture series. David Feldman, MD, professor of medicine at Stanford, explores the biological action of Vitamin D beyond its widely understood role in the information and maintenance of bone. E
From playlist Feature | Medcast
(March 16, 2010) David Spiegel, Stanford Professor in the Department of Psychiatry and Behavioral Sciences, discusses hypnosis, the mind, and its therapeutic interaction with the body from helping patients stop smoking to prolonging the lives of cancer patients. Stanford University: ht
From playlist Lecture Collection | Mini Med School
Ruth Patterson, Ph.D. on Time-Restricted Eating in Humans & Breast Cancer Prevention
This episode features Dr. Ruth Patterson, a professor in the UC San Diego Department of Family Medicine and Public Health as well as Associate Director of Population Sciences and leader of the Cancer Prevention program at Moores Cancer Center at UC San Diego Health. ▶︎ Get the show notes!
From playlist Frequent Topic: Dietary Fasting
Elke Markert - Conference in Honor of Arnold J. Levine
From the conference in honor of Arnold J. Levine at the Institute for Advanced Study, September 12–13, 2019. More videos on http://video.ias.edu
From playlist Conference in Honor of Arnold J. Levine
Dr. Steve Horvath on epigenetic aging to predict healthspan: the DNA PhenoAge and GrimAge clocks
Steve Horvath, PhD, ScD is a professor of human genetics and biostatistics at UCLA's Fielding School of Public Health. Dr. Horvath is the creator of the Horvath Epigenetic Aging Clock. His work incorporates elements of biostatistics, genetics, epidemiology, epigenomics, and other fields of
From playlist Interviews
Yale AIDS Colloquium Series - Robert Dubrow
"Cancer Risk and Prevention in Persons Living with HIV" The burden of cancer among persons living with HIV/AIDS is substantial due to both impaired immune function and high prevalence of non-HIV cancer risk factors, such as smoking and oncogenic virus infections. Consequently, the two pi
From playlist Center for Interdisciplinary Research on AIDS
Alice Whittemore, Stanford University: Big Data in Biomedicine Conference
Bringing together thought leaders in large-scale data analysis and technology to transform the way we diagnose, treat and prevent disease. Learn more: http://stanford.io/1M8v9ra
From playlist Big Data in Biomedicine Conference 2015
Lecture 1: Genomic Introduction
MIT HST.512 Genomic Medicine, Spring 2004 Instructor: Prof. Isaac Samuel Kohane View the complete course: https://ocw.mit.edu/courses/hst-512-genomic-medicine-spring-2004/ YouTube Playlist: https://www.youtube.com/watch?v=_-gQchCLmXk&list=PLUl4u3cNGP613PJMNmRjAIdBr76goU1V5 The future is
From playlist MIT HST.512 Genomic Medicine, Spring 2004
November 10, 2008 lecture by Paul Ewald for the Stanford Continuing Studies course on Darwin's Legacy (DAR 200). Dr. Ewald speaks about how several pathogenic viruses have evolved over time to break down the cell's barriers to several types of cancer. He suggests that further research will
From playlist Lecture Collection | Darwin's Legacy
Overcoming Drug Resistance to Cancer Therapies
Charles L. Sawyers, MD delivers a lecture on overcoming drug resistance to Cancer therapies, one of a series of lectures from The Yale School of Medicine Bicentennial Symposium, "Biomedicine in the New Century," which took place over April 28--29, 2011.
From playlist The Yale School of Medicine Bicentennial Symposium
Breast Cancer gets Worse in the Spring and Fall. But...Why?
Seasonal illnesses from infectious diseases aren’t a new concept, but a few decades ago public health experts began to notice the same behavior in some non-infectious diseases like breast cancer. These patterns have helped us learn a lot about how our bodies interact with the environment.
From playlist Biology
New Perspectives on Menopausal Hormones and Heart Disease
July 18, 2007 presentation by Marcia Stefanick for the Stanford School of Medicine Medcast lecture series. Recent Women's Health Initiative (WHI) studies demonstrated that hormone therapy carries a number of health risks in woman not considered earlier, such as the increased likelihood
From playlist Feature | Medcast
Marcello Delitala: Combination therapies and drug resistance in heterogeneous tumoral populations
Abstract: How combination therapies can reduce the emergence of cancer resistance? Can we exploit intra-tumoral competition to modify the effectiveness of anti-cancer treatments? Bearing these questions in mind, we present a mathematical model of cancer-immune competition under therapies.
From playlist Mathematics in Science & Technology